Susunod

Auto-play

Dr. Ai on Potential With Mogamulizumab in CTCL

3 Mga view • 08/09/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, speaks to the relevance of mogamulizumab (Poteligeo) in treating Sezary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play